Spots Global Cancer Trial Database for Copanlisib Pharmacodynamic Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Copanlisib Pharmacodynamic Study
Official Title: A Phase I Pharmacodynamic Study of Copanlisib (BAY 80-6946) as Monotherapy in Patients With Non-Hodgkin's Lymphoma and Solid Tumors
Study ID: NCT02155582
Conditions
Interventions
Study Description
Brief Summary: This study aims to analyze what the study drug does to the body and its relationship to drug levels and safety after patients with advanced cancer have been treated with copanlisib in different dose groups.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
, Bruxelles - Brussel, , Belgium
, Bruxelles - Brussel, , Belgium
, Gent, , Belgium
, Caen Cedex 5, , France
, Lille, , France
, Nice Cedex 2, , France
, Pierre Benite, , France
, Sutton, Surrey, United Kingdom
, London, , United Kingdom
Contact Details
Name: Bayer Study Director
Affiliation: Bayer
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
